Faculty, Staff and Student Publications
Language
English
Publication Date
1-1-2024
Journal
Journal of Investigative Medicine High Impact Case Reports
DOI
10.1177/23247096241240176
PMID
38504422
PMCID
PMC10953106
PubMedCentral® Posted Date
March 2024
PubMedCentral® Full Text Version
Post-print
Abstract
Gastric cancer ranks as the fifth leading cause of global cancer incidences, exhibiting varied prevalence influenced by geographical, ethnic, and lifestyle factors, as well as
Keywords
Humans, Aged, Stomach Neoplasms, Helicobacter Infections, Helicobacter pylori, Germ Cells, Ataxia Telangiectasia Mutated Proteins, Phthalazines, Piperazines, olaparib, PARP inhibitor, gastric cancer, germline ATM mutation
Published Open-Access
yes
Recommended Citation
Chan, Kok Hoe; Rutazanaa, Darius; Wray, Curtis; et al., "Promising Response of Olaparib in Patient With Germline ATM-Mutated Metastatic Gastric Cancer" (2024). Faculty, Staff and Student Publications. 568.
https://digitalcommons.library.tmc.edu/uthmed_docs/568
Included in
Digestive System Diseases Commons, Gastroenterology Commons, Internal Medicine Commons, Medical Sciences Commons, Mental and Social Health Commons, Surgery Commons